Trially has raised $4.7m in a seed funding round and introduced its agentic AI solution, Margo, designed to increase study ...

Suzhou is at the heart of China’s growing biotech ecosystem and its push for global clinical trial integration. Image credit: JaCZhou/Getty Images Driven by regulatory reforms that are accelerating ...

Nektar Therapeutics has presented data of its atopic dermatitis (AD) candidate rezpeg (rezpegaldesleukin), which sent the company’s stock flying. In the RESOLVE-AD trial (NCT06136741), the mean ...

AstraZeneca obtained the global rights to Saphnelo via an exclusive licensing and partnership agreement with Medarex in 2004. Credit: Grand Warszawski / Shutterstock.com. AstraZeneca’s fully human ...

Johnson & Johnson (J&J) and Protagonist Therapeutics’ icotrokinra has outperformed BMS’s Sotyktu (deucravacitinib) in treating patients with moderate-to-severe plaque psoriasis. In the Phase III ...

In the head-to-head trial, Lilly’s oral drug emerged on top, outperforming Novo Nordisk’s semaglutide.

REDCap Cloud (nPhase) has introduced a new platform to unify real-world evidence with clinical study data within a single system.

Despite missing the primary endpoint, aTyr Pharma still sees a future for the drug as it plans further FDA discussions.

Belite Bio has concluded the final participant visit in its Phase III DRAGON study, which is focused on assessing the ...

Amidst significant shifts in the pharmaceutical industry, the number of clinical trials has surged over the first half of ...

On this episode, the healthcare editorial team unpicks several key trials and trends from this year’s event, held from 29 ...